Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10.

Shipley, William U; Lu, J D; Pilepich, Michael V; Heydon, Kateri; Roach, Mack; Wolkov, Harvey B; Sause, William T; Rubin, Philip; Lawton, Colleen A; Machtay, Mitchell

Shipley, William U; Lu, J D; Pilepich, Michael V; Heydon, Kateri; Roach, Mack; Wolkov, Harvey B; Sause, William T; Rubin, Philip; Lawton, Colleen A; Machtay, Mitchell.

Affiliation

Shipley WU; Massachusetts General Hospital, Boston, MA 02114, USA. wshipley@partners.org

Int J Radiat Oncol Biol Phys ; 54(5): 1302-10, 2002 Dec 01.

Article in En | MEDLINE | ID: mdl-12459350

Subject(s)

Chemotherapy, Adjuvant; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/radiotherapy; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal/therapeutic use; Disease-Free Survival; Flutamide/therapeutic use; Goserelin/therapeutic use; Humans; Male; Middle Aged; Prostatic Neoplasms/mortality; Recurrence; Salvage Therapy; Time Factors; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Chemotherapy, Adjuvant Type of study: Clinical_trials / Guideline Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2002 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links